Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Mallinckrodt
Colorcon
Merck
Federal Trade Commission
QuintilesIMS

Generated: August 18, 2019

DrugPatentWatch Database Preview

Claims for Patent: 8,674,825

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,674,825
Title:Pharma-informatics system
Abstract: Compositions, systems and methods that allow for the detection of the actual physical delivery of a pharmaceutical agent to a body are provided. Embodiments of the compositions include an identifier and an active agent. The invention finds use in a variety of different applications, including but not limited to, monitoring of therapeutic regimen compliance, tracking the history of pharmaceutical agents, etc.
Inventor(s): Zdeblick; Mark (Portola Valley, CA), Thompson; Andrew (Portola Valley, CA), Pikelny; Aleksandr (Los Angeles, CA), Robertson; Timothy (Belmont, CA)
Assignee: Proteus Digital Health, Inc. (Redwood City, CA)
Application Number:12/404,184
Patent Claims: 1. A receiver comprising a receiver element configured to receive a conductively transmitted signal emitted by an identifier that conductively transmits a signal upon contact with an internal target physiological site, wherein the receiver comprises a data storage element, and wherein the data storage element is configured to store data comprising at least one of time, date and identity of an ingested composition.

2. The receiver according to claim 1, wherein the conductively transmitted signal has a frequency that ranges from 1 KHz to 100 MHz.

3. The receiver according to claim 2, wherein the conductively transmitted signal has a frequency that ranges from 1 KHz to 70 KHz.

4. The receiver according to claim 2, wherein the conductively transmitted signal has a frequency that ranges from: 30 KHz to 300 KHz; 160 KHz to 190 KHz or 3 KHz to 30 KHz.

5. The receiver according to claim 1, wherein the receiver element comprises a receiving antenna configured to detect potential differences in a body.

6. The receiver according to claim 5, wherein the receiving antenna comprises two electrodes spaced apart from each other at a distance sufficient to detect a differential voltage.

7. The receiver according to claim 1, wherein the receiver comprises an amplifier.

8. The receiver according to claim 1, wherein the receiver comprises a filter.

9. The receiver according to claim 1, wherein the receiver comprises a demodulator.

10. The receiver according to claim 1, wherein the receiver is configured to retransmit data to a separate external device.

11. The receiver according to claim 10, wherein the receiver comprises RF circuitry and is configured to retransmit data to a separate external device by using an RF communication protocol.

12. The receiver according to claim 1, wherein the receiver is configured as an in vivo receiver.

13. The receiver according to claim 1, wherein the receiver is configured as an ex vivo receiver.

14. The receiver according to claim 1, wherein the receiver comprises a physiological sensor.

15. A receiver comprising: a receiver element comprising two electrodes spaced apart from each other at a distance sufficient to detect a differential voltage in a body; a data storage element; an amplifier; and a demodulator; wherein the receiver is configured to retransmit data to a separate external device, and wherein the data storage element is configured to store data comprising at least one of time, date and identity of an ingested composition.

16. The receiver according to claim 15, wherein the receiver is configured as an in vivo receiver.

17. The receiver according to claim 15, wherein the receiver is configured as an ex vivo receiver.

18. A system comprising: an identifier that conductively transmits a signal upon contact with an internal target physiological site; and a receiver comprising a receiver element configured to receive a conductively transmitted signal emitted by the identifier and a data storage element configured to store data comprising at least one of time, date and identity of an ingested composition.

19. The system according to claim 18, wherein the conductively transmitted signal has a frequency that ranges from 1 KHz to 100 MHz.

20. The system according to claim 18, wherein the receiver element comprises a receiving antenna configured to detect potential differences in a body.

21. The system according to claim 20, wherein the receiving antenna comprises two electrodes spaced apart from each other at a distance sufficient to detect a differential voltage.

22. The system according to claim 18, wherein the receiver comprises an amplifier.

23. The system according to claim 18, wherein the receiver comprises a demodulator.

24. The receiver according to claim 18, wherein the receiver is configured to retransmit data to a separate external device.

25. A method comprising receiving a signal at a receiver comprising a receiver element configured to receive a conductively transmitted signal emitted by an identifier that conductively transmits a signal upon contact with an internal target physiological site, wherein the receiver further comprises a data storage element, and wherein the method further comprises storing, at the data storage element, at least one of time, date and identity of an ingested composition.

26. The method according to claim 25, wherein the signal is a conductively transmitted signal.

27. The method according to claim 26, wherein the conductively transmitted signal has a frequency that ranges from 1 KHz to 100 MHz.

28. The method according to claim 25, wherein the receiver element comprises a receiving antenna configured to detect potential differences in a body.

29. The method according to claim 28, wherein the receiving antenna comprises two electrodes spaced apart from each other at a distance sufficient to detect a differential voltage.

30. The method according to claim 25, wherein the receiver comprises an amplifier.

31. The method according to claim 25, wherein the receiver comprises a demodulator.

32. The method according to claim 25, wherein the receiver is configured to retransmit data to a separate external device.

33. The method according to claim 32, wherein the method further comprises transmitting a signal from the receiver to the separate external device.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Julphar
Fuji
Fish and Richardson
Chubb
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.